# Open Clinical Study, Comparing Non-inferiority of Chronic Plaque Psoriasis

> **NCT01279629** · — · SUSPENDED · sponsor: **Glenmark Farmacêutica Ltda** · enrollment: 50 (estimated)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** Each patient will receive a sample of the drug test (tazarotene 0.1%) and a control sample of the drug (calcipotriene 0.005%).

## Key facts

- **NCT ID:** NCT01279629
- **Lead sponsor:** Glenmark Farmacêutica Ltda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2011-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01279629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01279629, "Open Clinical Study, Comparing Non-inferiority of Chronic Plaque Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01279629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*